Oral fenretinide in biochemically recurrent prostate cancer: a California cancer consortium phase II trial.
Cheung E, Pinski J, Dorff T, Groshen S, Quinn DI, Reynolds CP, Maurer BJ, Lara PN Jr, Tsao-Wei DD, Twardowski P, Chatta G, McNamara M, Gandara DR.
Cheung E, et al. Among authors: quinn di.
Clin Genitourin Cancer. 2009 Jan;7(1):43-50. doi: 10.3816/CGC.2009.n.008.
Clin Genitourin Cancer. 2009.
PMID: 19213668
Clinical Trial.